Definium Therapeutics, Inc.

DFTX

DFTXDefinium Therapeutics, Inc. US flag

NASDAQ Global Select

22.87

USD

+0.01

- -

2.49BMarket Cap

Income Statement (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -
- Operating Expenses	33	94	66	94	104	166
+ Selling, General & Admin	14	59	30	42	39	49
+ Research & Development	19	35	36	52	65	118
+ Other Operating Expense	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-33	-94	-66	-94	-104	-166
- Non-Operating (Income) Loss	1	- -	-10	2	5	17
+ Interest Expense, Net	- -	- -	- -	-5	-9	-5
+ Interest Expense	- -	- -	- -	1	2	5
- Interest Income	- -	- -	- -	6	12	11
+ Other Non-Op (Income) Loss	1	- -	-10	7	14	23
Pretax Income	-34	-94	-57	-96	-109	-184
- Income Tax Expense (Benefit)	- -	-1	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-34	-93	-57	-96	-109	-184
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-34	-93	-57	-96	-109	-184
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-34	-93	-57	-96	-109	-184
- Preferred Dividends	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-34	-93	-57	-96	-109	-184
EBIT	-33	-94	-66	-94	-104	-166
EBITDA	-33	-91	-63	-91	-103	-166
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
EBITA	-33	-94	-66	-94	-104	-166
Gross Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	3	3	3	1	- -
Basic Weighted Avg Shares	18	27	31	39	70	- -
Basic EPS, GAAP	-1.91	-3.4	-1.84	-2.44	-1.54	- -
Basic EPS from Cont Ops	-1.91	-3.4	-1.84	-2.44	-1.54	- -
Diluted Weighted Avg Shares	18	27	31	39	70	- -
Diluted EPS, GAAP	-1.91	-3.4	-1.84	-2.44	-1.54	- -
Diluted EPS from Cont Ops	-1.91	-3.4	-1.84	-2.44	-1.54	- -

Balance Sheet (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	82	137	146	104	282	419
+ Cash, Cash Equivalents & STI	80	134	142	100	274	412
+ Cash & Cash Equivalents	80	134	142	100	274	258
+ ST Investments	- -	- -	- -	- -	- -	154
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -
+ Other ST Assets	1	4	4	4	8	8
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	27	24	21	21	21
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	27	24	21	21	21
+ Total Intangible Assets	- -	27	24	20	20	20
+ Goodwill	- -	20	20	20	20	20
+ Other Intangible Assets	- -	7	4	1	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	1	1
Total Assets	82	164	170	125	302	440
+ Payables & Accruals	3	8	5	11	8	16
+ Accounts Payable	2	4	2	4	2	5
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	4	3	7	6	11
+ ST Debt	- -	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	2	13	21	30	50
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	2	13	21	30	50
Total Current Liabilities	3	10	18	32	39	67
+ LT Debt	- -	- -	- -	14	22	41
+ LT Borrowings	- -	- -	- -	14	22	41
+ LT Finance Leases	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	3	2	1	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	3	2	1	- -	- -	- -
Total Noncurrent Liabilities	3	2	1	14	22	41
Total Liabilities	6	12	19	46	61	108
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	120	288	345	368	640	914
+ Common Stock	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	120	288	345	368	640	914
- Treasury Stock	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-45	-138	-194	-290	-399	-583
+ Other Equity	- -	1	1	- -	1	1
Equity Before Minority Interest	76	152	151	78	241	332
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	76	152	151	78	241	332
Total Liabilities & Equity	82	164	170	125	302	440
Shares Outstanding	20	28	38	41	75	99
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	- -
Net Debt	-80	-134	-142	-86	-252	-217
Net Debt to Equity	-105.57	-88.05	-94.19	-109.52	-104.32	-65.37
Tangible Common Equity Ratio	93.07	91.01	86.97	55.42	78.49	74.35
Current Ratio	27.1	13.18	8.16	3.22	7.25	6.29
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-34	-93	-57	-96	-109	-184
+ Depreciation & Amortization	- -	3	3	3	1	- -
+ Non-Cash Items	8	43	7	22	32	43
+ Stock-Based Compensation	7	43	14	15	17	20
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	1	- -	-6	7	15	23
+ Chg in Non-Cash Work Cap	2	2	-4	6	-3	9
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	-2	- -	- -	-4	- -
+ Inc (Dec) in Accts Payable	3	5	-2	7	1	9
+ Inc (Dec) in Other	- -	-1	-1	-1	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-24	-46	-50	-64	-79	-132
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	72	82	42	- -	251	259
+ Increase in Capital Stock	72	82	42	- -	251	259
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	-152
+ Dec in LT Investment	- -	- -	- -	- -	- -	117
+ Inc in LT Investment	- -	- -	- -	- -	- -	-268
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	- -	-152
+ Dividends Paid	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	22	10	20
+ Cash From Debt	- -	- -	- -	23	10	42
+ Repayments of Debt	- -	- -	- -	-1	- -	-22
+ Other Financing Activities	25	17	17	- -	-8	-12
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	97	99	59	22	253	267
Effect of Foreign Exchange Rates	- -	1	- -	- -	- -	- -
Net Changes in Cash	73	53	9	-43	174	-16
EBITDA	-33	-91	-63	-91	-103	-166
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Free Cash Flow	-24	-46	-50	-64	-79	-132
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-46	-50	-43	-69	-112
Free Cash Flow per Basic Share	-1.33	-1.67	-1.62	-1.64	-1.12	- -
Price/Free Cash Flow	-34.41	-12.37	-1.35	-2.23	-6.2	- -
Cash Flow to Net Income	0.7	0.49	0.88	0.67	0.73	0.72
Capital Expenditures	- -	- -	- -	- -	- -	- -